181. BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.
作者: Alexander C Schmidt.;Lee Fairlie.;Elizabeth Hellström.;Angelique Luabeya Kany Kany.;Keren Middelkoop.;Kogieleum Naidoo.;Gonasagrie Nair.;Anele Gela.;Elisa Nemes.;Thomas J Scriba.;Amy Cinar.;Nicole Frahm.;Robin Mogg.;David Kaufman.;Michael W Dunne.;Mark Hatherill.; .
来源: N Engl J Med. 2025年392卷18期1789-1800页
In a previous phase 2 trial, bacille Calmette-Guérin (BCG) revaccination was not shown to provide protection from primary Mycobacterium tuberculosis infection but prevented sustained M. tuberculosis infection, defined by an initial conversion on a QuantiFERON-TB (QFT) test (an interferon-γ release assay) from negative to positive, followed by two additional positive QFT tests at 3 and 6 months after the initial conversion (a secondary end point). A vaccine efficacy of 45% (95% confidence interval [CI], 6 to 68) was observed.
197. The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption.
作者: Susan M Gapstur.;Daniela Mariosa.;Luciana Neamtiu.;Suzanne T Nethan.;Jürgen Rehm.;Taisia Huckle.;David H Jernigan.;Elizabeth A O'Connor.;Mindaugas Štelemėkas.;Peter Allebeck.;Sawitri Assanangkornchai.;Nicholas Carah.;Surasak Chaiyasong.;Samantha Cukier.;The Son Dao.;Rijo M John.;Richard Matzopoulos.;Petra S Meier.;Paula O'Brien.;Guillermo Paraje.;Robin Room.;Claire Wilkinson.;Norman D Maldonado.;Tim Stockwell.;Maria Neufeld.;Dag Rekve.;Béatrice Lauby-Secretan.
来源: N Engl J Med. 2025年392卷17期1752-1759页 |